XML 47 R34.htm IDEA: XBRL DOCUMENT v3.23.1
Operating Segments (Tables)
3 Months Ended
Mar. 31, 2023
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment
The table below summarizes the Company's results by operating segment:
InsuranceNon-InsuranceCorporate/OtherEliminationsConsolidated Total
Three months ended March 31, 2023(in thousands)
Premiums earned, net (net of ceded premiums of $122)
$317,086 $— $— $— $317,086 
Non-Insurance revenue— 205,783 — — 205,783 
Other income 1,839 428 17,310 (14,671)4,906 
Intersegment revenues — — 23,231 (23,231)— 
Net medical claims incurred274,504 197,701 3,448 (3,163)472,490 
Gross profit (loss)$44,421 $8,510 $37,093 $(34,739)$55,285 
Total assets$467,392 $716,104 $936,903 $(666,810)$1,453,589 
InsuranceNon-InsuranceCorporate/OtherEliminationsConsolidated Total
Three months ended March 31, 2022(in thousands)
Premiums earned, net (net of ceded premiums of $119)
$278,169 $— $— $— $278,169 
Non-Insurance revenue— 594,898 — — 594,898 
Other income271 — 27,399 (26,358)1,312 
Intersegment revenues— — 19,136 (19,136)— 
Net medical claims incurred268,126 593,999 2,628 (3,031)861,722 
Gross profit (loss)$10,314 $899 $43,907 $(42,463)$12,657 
Total assets$406,167 $1,859,741 $1,113,735 $(699,749)$2,679,894 
Schedule of Reconciliation of Revenue from Segments to Consolidated
A reconciliation of the reportable segments' gross profit to the Net loss included in the Consolidated Statements of Operations and Comprehensive Loss is as follows:
Three months ended March 31,20232022
(in thousands)
Gross profit$55,285 $12,657 
Salaries and benefits70,207 69,091 
General and administrative expenses59,215 57,697 
Premium deficiency reserve benefit(1,810)(27,476)
Depreciation and amortization279 826 
Interest expense— 403 
Gain on investment— (12,394)
Net loss$(72,606)$(75,490)